– Apogem Capital (“Apogem”), a leading private markets investor, announced the final close of Apogem Secondary Fund VII (“ASF VII”) at its $1.43 billion hard cap.
– Including employee commitments, ASF VII raised over $1.45 billion, surpassing its $1 billion target and more than doubling the size of its predecessor fund.
– @Josh Niedner, CEO of Apogem Capital, highlighted the firm’s focused middle market strategy, disciplined underwriting, and extensive private equity sponsor network.
– ASF VII continues Apogem’s strategy of building a diversified portfolio of GP-led and LP secondary transactions in the North American middle market.
– Apogem has a strong track record as a sole buyer in LP secondaries and as a lead or co-lead investor in GP-led transactions.
– Michael Zeleniuch, Managing Director and Head of Liquidity Solutions, emphasized the Fund’s ability to provide tailored capital solutions to middle market GPs and LPs.
– ASF VII received strong support from existing limited partners and attracted new institutional investors, including public and private pension plans, family offices, and RIAs.
– Apogem employees and its parent company, New York Life Insurance Company, also made significant commitments to the Fund.
– The Fund leverages Apogem’s scale as a $44 billion private markets investment manager and its connectivity across private equity and credit programs.
– ASF VII positions Apogem to continue delivering innovative, high-quality liquidity solutions amid evolving private equity market demands.
– Including employee commitments, ASF VII raised over $1.45 billion, surpassing its $1 billion target and more than doubling the size of its predecessor fund.
– @Josh Niedner, CEO of Apogem Capital, highlighted the firm’s focused middle market strategy, disciplined underwriting, and extensive private equity sponsor network.
– ASF VII continues Apogem’s strategy of building a diversified portfolio of GP-led and LP secondary transactions in the North American middle market.
– Apogem has a strong track record as a sole buyer in LP secondaries and as a lead or co-lead investor in GP-led transactions.
– Michael Zeleniuch, Managing Director and Head of Liquidity Solutions, emphasized the Fund’s ability to provide tailored capital solutions to middle market GPs and LPs.
– ASF VII received strong support from existing limited partners and attracted new institutional investors, including public and private pension plans, family offices, and RIAs.
– Apogem employees and its parent company, New York Life Insurance Company, also made significant commitments to the Fund.
– The Fund leverages Apogem’s scale as a $44 billion private markets investment manager and its connectivity across private equity and credit programs.
– ASF VII positions Apogem to continue delivering innovative, high-quality liquidity solutions amid evolving private equity market demands.